![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » iCAD Granted CE Mark for Breast Cancer Detection Device
iCAD Granted CE Mark for Breast Cancer Detection Device
![](https://www.fdanews.com/ext/resources/test/Device_Images6/iCad_Logo.png?t=1520035907&width=430)
March 2, 2018
iCAD received a CE Mark for its PowerLook Tomo Detection 2.0, the company’s second deep-learning based computer aided detection solution for breast cancer.
The PowerLook uses an algorithm that is trained to detect malignancies and determine the probability of cases having malignant findings. It provides radiologists a “certainty of finding” score for each detected lesion.
The device is compatible with Hologic, GE and Siemens systems.
Upcoming Events
-
21Oct